Skip to main content

Table 3 Clinical and biochemical characteristics of patients with diabetic retinopathy

From: Timing of kidney biopsy in type 2 diabetic patients: a stepwise approach

Characteristics

Isolated DN

(Group 1)

n = 100

NDRD ± DN

(Group 2)

n = 12

P-value

Gender (male)

55 (55%)

10 (83.3%)

0.06

Age (year)

55.3 ± 11.5

58.8 ± 8.2

0.111

Body weight (kg)

67.3 (56.3, 77.4)

71.8 (67.4, 74)

0.451

Height (cm)

163.4 ± 8.1

165.3 ± 8.8

0.477

BMI (kg/m2)

24.4 (22.2, 28.4)

25.5 (24.2, 28.3)

0.623

Duration of diabetes (yr)

10 (4, 15.8)

6 (3.5, 7.5)

0.217

Diabetic retinopathy

 PDR

56 (56%)

2 (16.7%)

0.01

 ME

15 (15%)

2 (16.7%)

1

 PRP

54 (54%)

2 (16.7%)

0.029

 PC

13 (13%)

0 (0%)

0.354

 IVI

29 (29%)

1 (8.3%)

0.176

 VT

8 (8%)

0 (0%)

0.596

HbA1c (%)

7.1 (6.3, 9.1)

7.8 (6.5, 9.6)

0.437

Serum creatinine (mg/dL)

2.9 (1.6, 4.7)

3.7 (1.4, 10.8)

0.316

eGFR (mL/min/1.73 m2)

20.4 (10.9, 39.9)

19.1 (4.3, 49.7)

0.366

UPCR (1000 mg/g)

9.1 (6.2, 12.5)

7.2 (3.1, 11.9)

0.214

Urinary red blood cells/HPF

4 (4, 8)

8 (4, 43)

0.004

Urinary white blood cells/HPF

1 (1, 4)

1 (1, 4)

0.69

Right kidney size (cm)

11.6 ± 1.1

11.7 ± 1.2

0.785

Left kidney size (cm)

11.5 ± 1.2

11.8 ± 1.0

0.481

  1. Values were presented as median (Q1, Q3), mean ± SD, or n (%)
  2. DN diabetic nephropathy, NDRD non-diabetic renal disease, BMI body mass index, PDR proliferative diabetic retinopathy, ME macular edema, PRP panretinal photocoagulation, PC focal photocoagulation, IVI intravitreal injection, VT vitrectomy, UPCR urine protein-to-creatinine ratio